




Searching News Database: glaucoma
HSMN NewsFeed - 28 Jan 2025
AI Optics Receives FDA Clearance, Increasing Patient Access to Retinal Screening
AI Optics Receives FDA Clearance, Increasing Patient Access to Retinal Screening
HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
HSMN NewsFeed - 5 May 2023
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
HSMN NewsFeed - 15 Jul 2021
iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
HSMN NewsFeed - 7 Apr 2021
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
HSMN NewsFeed - 16 Nov 2020
iSTAR Medical's glaucoma device MINIject shows positive one-year results in European trial
iSTAR Medical's glaucoma device MINIject shows positive one-year results in European trial
HSMN NewsFeed - 14 Jul 2020
CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation
CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation
HSMN NewsFeed - 7 May 2020
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
HSMN NewsFeed - 2 Dec 2019
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
HSMN NewsFeed - 2 Jan 2019
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
HSMN NewsFeed - 12 Apr 2018
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
HSMN NewsFeed - 22 Mar 2018
LIGHTMED Corporation Appoints Dennis Dowell as Director of Sales and Marketing for North America
LIGHTMED Corporation Appoints Dennis Dowell as Director of Sales and Marketing for North America
HSMN NewsFeed - 8 Jan 2018
I-PEN(R), I-DROP(R) and I-PLUG(R) now available in Spain and Portugal through Partnership with IMEX
I-PEN(R), I-DROP(R) and I-PLUG(R) now available in Spain and Portugal through Partnership with IMEX
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 31 Oct 2017
Mitosol(R)'s Orphan Drug Designation is Expanded for All Glaucoma Surgery
Mitosol(R)'s Orphan Drug Designation is Expanded for All Glaucoma Surgery
HSMN NewsFeed - 2 May 2017
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
HSMN NewsFeed - 28 Feb 2017
IRIDEX Launches New FDA-Cleared Probe At The Annual American Glaucoma Society Meeting
IRIDEX Launches New FDA-Cleared Probe At The Annual American Glaucoma Society Meeting
HSMN NewsFeed - 2 Feb 2017
Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
HSMN NewsFeed - 3 Jan 2017
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
HSMN NewsFeed - 23 Aug 2016
Kalytera Therapeutics Appoints Dr. Andrew Salzman as Chief Medical Officer
Kalytera Therapeutics Appoints Dr. Andrew Salzman as Chief Medical Officer
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
HSMN NewsFeed - 23 Mar 2016
Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing
Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing
HSMN NewsFeed - 16 Feb 2016
IRIDEX Receives CE Mark for Cyclo G6(TM) Laser System for the Treatment of Multiple Stages of Glaucoma
IRIDEX Receives CE Mark for Cyclo G6(TM) Laser System for the Treatment of Multiple Stages of Glaucoma
HSMN NewsFeed - 27 Jan 2016
InnFocus MicroShunt(R) 3-Year Results of a Long Term Clinical Trial Show Long Lasting IOP Reduction
InnFocus MicroShunt(R) 3-Year Results of a Long Term Clinical Trial Show Long Lasting IOP Reduction
HSMN NewsFeed - 3 Dec 2015
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's Portfolio of Glaucoma Products
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's Portfolio of Glaucoma Products
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 29 Jun 2015
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
HSMN NewsFeed - 19 Jun 2015
OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
HSMN NewsFeed - 13 Aug 2014
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
HSMN NewsFeed - 16 Apr 2014
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
HSMN NewsFeed - 19 Sep 2013
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
HSMN NewsFeed - 3 Sep 2013
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
HSMN NewsFeed - 25 Jul 2013
Aerie Pharmaceuticals Names Vicente Anido, Jr., Current Chairman of the Board, as Chief Executive Officer
Aerie Pharmaceuticals Names Vicente Anido, Jr., Current Chairman of the Board, as Chief Executive Officer
HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
HSMN NewsFeed - 11 Mar 2013
Mobius Therapeutics(TM) Receives Payment Indicator for Reimbursement of Mitosol(R)
Mobius Therapeutics(TM) Receives Payment Indicator for Reimbursement of Mitosol(R)
HSMN NewsFeed - 20 Feb 2013
Mobius Therapeutics(TM) Provides Update on Recall of Two Lots of Mitosol(R)
Mobius Therapeutics(TM) Provides Update on Recall of Two Lots of Mitosol(R)
HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
HSMN NewsFeed - 3 Jan 2013
Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring
Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring
HSMN NewsFeed - 12 Dec 2012
Sucampo Announces FDA Approval of an sNDA for RESCULA(R) (unoprostone isopropyl)
Sucampo Announces FDA Approval of an sNDA for RESCULA(R) (unoprostone isopropyl)
HSMN NewsFeed - 11 Dec 2012
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
HSMN NewsFeed - 13 Nov 2012
Transcend Medical Announces 12-Month European Study Results of the CyPass Micro-Stent(R) at AAO 2012
Transcend Medical Announces 12-Month European Study Results of the CyPass Micro-Stent(R) at AAO 2012
HSMN NewsFeed - 18 Oct 2012
Aerie Pharmaceuticals Appoints Richard J. Rubino as Chief Financial Officer
Aerie Pharmaceuticals Appoints Richard J. Rubino as Chief Financial Officer
HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
HSMN NewsFeed - 20 Jun 2012
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
HSMN NewsFeed - 11 Oct 2011
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
HSMN NewsFeed - 24 Mar 2011
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
HSMN NewsFeed - 12 Oct 2010
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
HSMN NewsFeed - 19 Jul 2010
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
HSMN NewsFeed - 12 May 2010
Paradigm Medical Names Charles Pritchard as Vice President of Sales and Marketing
Paradigm Medical Names Charles Pritchard as Vice President of Sales and Marketing
HSMN NewsFeed - 30 Apr 2010
IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
HSMN NewsFeed - 5 Apr 2010
Altheos Completes $20 Million Series A Financing to Develop Next-Generation Glaucoma Treatment
Altheos Completes $20 Million Series A Financing to Develop Next-Generation Glaucoma Treatment
HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
HSMN NewsFeed - 3 Mar 2010
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
HSMN NewsFeed - 2 Feb 2010
STAAR Surgical's Visian(R) ICL(TM) is First Phakic Lens to Be Approved in Japan
STAAR Surgical's Visian(R) ICL(TM) is First Phakic Lens to Be Approved in Japan
HSMN NewsFeed - 10 Jan 2010
deCODE Finds Genetic Factors Impacting Key Clinical Measurements of Heart Activity and Disease Risk
deCODE Finds Genetic Factors Impacting Key Clinical Measurements of Heart Activity and Disease Risk
HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
HSMN NewsFeed - 17 Dec 2009
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
HSMN NewsFeed - 5 Oct 2009
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
HSMN NewsFeed - 4 Aug 2009
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
HSMN NewsFeed - 2 Jul 2009
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
HSMN NewsFeed - 11 Jun 2009
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
HSMN NewsFeed - 9 Jun 2009
STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System
STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System
HSMN NewsFeed - 2 Jun 2009
Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder
Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder
HSMN NewsFeed - 21 Apr 2009
Paradigm Medical Industries Expands Its US and Global Reach With New Sales Force
Paradigm Medical Industries Expands Its US and Global Reach With New Sales Force
HSMN NewsFeed - 20 Apr 2009
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
HSMN NewsFeed - 16 Apr 2009
Paradigm Medical Industries Signs Worldwide Distribution Agreement With CSO
Paradigm Medical Industries Signs Worldwide Distribution Agreement With CSO
HSMN NewsFeed - 16 Apr 2009
STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL
STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL
HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
HSMN NewsFeed - 6 Feb 2009
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
HSMN NewsFeed - 17 Jan 2009
Advanced Medical Optics Receives FDA Approval for TECNIS(R) Multifocal Intraocular Lens
Advanced Medical Optics Receives FDA Approval for TECNIS(R) Multifocal Intraocular Lens
HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
HSMN NewsFeed - 31 Oct 2008
Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
HSMN NewsFeed - 7 Oct 2008
Advanced Medical Optics Receives FDA Approval for Healon D(R) Viscoelastic for Ophthalmic Surgery
Advanced Medical Optics Receives FDA Approval for Healon D(R) Viscoelastic for Ophthalmic Surgery
HSMN NewsFeed - 9 Sep 2008
Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board
Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board
HSMN NewsFeed - 26 Aug 2008
Interventional Ophthalmology Procedure Indicated for Treatment of Glaucoma
Interventional Ophthalmology Procedure Indicated for Treatment of Glaucoma
HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
HSMN NewsFeed - 11 Jul 2008
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
HSMN NewsFeed - 24 Jun 2008
Advanced Medical Optics Enters into Cross-Licensing Patent Agreement with Alcon
Advanced Medical Optics Enters into Cross-Licensing Patent Agreement with Alcon
HSMN NewsFeed - 23 Jun 2008
Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
HSMN NewsFeed - 21 May 2008
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
HSMN NewsFeed - 14 May 2008
Advanced Medical Optics Receives FDA Clearance For iFS(TM) Advanced Femtosecond Laser
Advanced Medical Optics Receives FDA Clearance For iFS(TM) Advanced Femtosecond Laser
HSMN NewsFeed - 8 May 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
HSMN NewsFeed - 30 Apr 2008
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
HSMN NewsFeed - 4 Apr 2008
Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
HSMN NewsFeed - 1 Apr 2008
Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S.
Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S.
HSMN NewsFeed - 5 Mar 2008
Paradigm Medical Industries Introduces Advances on the LD400 Full-Field Autoperimetry System
Paradigm Medical Industries Introduces Advances on the LD400 Full-Field Autoperimetry System
HSMN NewsFeed - 29 Feb 2008
STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
HSMN NewsFeed - 31 Jan 2008
Advanced Medical Optics Enters into Phacoemulsification Patent Agreement with Bausch & Lomb
Advanced Medical Optics Enters into Phacoemulsification Patent Agreement with Bausch & Lomb
HSMN NewsFeed - 28 Jan 2008
Paradigm Medical Industries to Market Proprietary Electrophysiology Device for Early Detection of Glaucoma
Paradigm Medical Industries to Market Proprietary Electrophysiology Device for Early Detection of Glaucoma
HSMN NewsFeed - 30 Nov 2007
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
HSMN NewsFeed - 9 Oct 2007
Advanced Medical Optics Names New Chief Financial Officer, Announces Management Changes
Advanced Medical Optics Names New Chief Financial Officer, Announces Management Changes
HSMN NewsFeed - 8 Oct 2007
Study Shows Doctors and Contact Lens Wearers Don't See Eye to Eye When It Comes to Proper Lens Care
Study Shows Doctors and Contact Lens Wearers Don't See Eye to Eye When It Comes to Proper Lens Care
HSMN NewsFeed - 2 Oct 2007
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
HSMN NewsFeed - 27 Aug 2007
Advanced Medical Optics Hires Richard J. DeRisio as Vice President, Global Regulatory Affairs
Advanced Medical Optics Hires Richard J. DeRisio as Vice President, Global Regulatory Affairs
HSMN NewsFeed - 21 Aug 2007
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
HSMN NewsFeed - 5 Jul 2007
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
HSMN NewsFeed - 29 Jun 2007
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
HSMN NewsFeed - 28 Jun 2007
Paradigm Medical Industries Expands, Strengthens Global Sales and Marketing Effort
Paradigm Medical Industries Expands, Strengthens Global Sales and Marketing Effort
HSMN NewsFeed - 27 Jun 2007
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
HSMN NewsFeed - 14 Jun 2007
STAAR Surgical Creates New Leadership Position to Oversee Research, Development and Clinical Activities
STAAR Surgical Creates New Leadership Position to Oversee Research, Development and Clinical Activities
HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 23 May 2007
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
HSMN NewsFeed - 21 May 2007
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized Anxiety Disorder
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized Anxiety Disorder
HSMN NewsFeed - 3 May 2007
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
HSMN NewsFeed - 30 Apr 2007
Carl Zeiss Meditec: Benchmark for Eye Disease Treatment -- Company Ships 15,000th Ophthalmic Laser Worldwide
Carl Zeiss Meditec: Benchmark for Eye Disease Treatment -- Company Ships 15,000th Ophthalmic Laser Worldwide
HSMN NewsFeed - 30 Apr 2007
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
HSMN NewsFeed - 27 Apr 2007
Advanced Medical Optics Launches WhiteStar Signature(TM) Phacoemulsification System with Fusion(TM) Fluidics
Advanced Medical Optics Launches WhiteStar Signature(TM) Phacoemulsification System with Fusion(TM) Fluidics
HSMN NewsFeed - 18 Jan 2007
Carl Zeiss Meditec Announces FDA Clearance to Market VISUMAX Femtosecond Laser System
Carl Zeiss Meditec Announces FDA Clearance to Market VISUMAX Femtosecond Laser System
HSMN NewsFeed - 8 Jan 2007
Paradigm Medical Industries Announces Operations and Sales Management Reorganization
Paradigm Medical Industries Announces Operations and Sales Management Reorganization
HSMN NewsFeed - 4 Jan 2007
Advanced Medical Optics Updates Possible Timing for U.S. Launch of Tecnis(R) Multifocal Intraocular Lens
Advanced Medical Optics Updates Possible Timing for U.S. Launch of Tecnis(R) Multifocal Intraocular Lens
HSMN NewsFeed - 29 Dec 2006
Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide)
Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide)
HSMN NewsFeed - 13 Dec 2006
FDA Accepts New Drug Application for SANCTURA XR(TM) Submitted by Indevus
FDA Accepts New Drug Application for SANCTURA XR(TM) Submitted by Indevus
HSMN NewsFeed - 29 Nov 2006
Coronado Industries PNT Glaucoma Treatment to Be Featured at Italian Society of Ophthalmology (SOI) Meeting
Coronado Industries PNT Glaucoma Treatment to Be Featured at Italian Society of Ophthalmology (SOI) Meeting
HSMN NewsFeed - 28 Nov 2006
Carl Zeiss Meditec Named Ophthalmologists' First Choice for Optical Biometry
Carl Zeiss Meditec Named Ophthalmologists' First Choice for Optical Biometry
HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
HSMN NewsFeed - 10 Nov 2006
Transcend Medical, Inc., Announces New CEO Appointment and Series 'A' Funding
Transcend Medical, Inc., Announces New CEO Appointment and Series 'A' Funding
HSMN NewsFeed - 6 Nov 2006
Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Madaus GmbH
Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Madaus GmbH
HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
HSMN NewsFeed - 20 Oct 2006
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
HSMN NewsFeed - 21 Sep 2006
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
HSMN NewsFeed - 18 Sep 2006
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
HSMN NewsFeed - 12 Sep 2006
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
HSMN NewsFeed - 24 Jul 2006
Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound
Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound
HSMN NewsFeed - 10 Jul 2006
Advanced Medical Optics Announces Settlement With Alcon of Patent Infringement Suits
Advanced Medical Optics Announces Settlement With Alcon of Patent Infringement Suits
HSMN NewsFeed - 7 Jul 2006
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
HSMN NewsFeed - 22 May 2006
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
HSMN NewsFeed - 9 May 2006
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder
Additional items found! 296

Members Archive contains
296 additional stories matching:
glaucoma
(Password required)
glaucoma
(Password required)